Total Payments
$10,168
2024 Payments
$1,471
Companies
27
Transactions
507
Medicare Patients
2,610
Medicare Billing
$450,700
Payment Breakdown by Category
Food & Beverage$9,574 (94.2%)
Education$592.66 (5.8%)
Travel$1.50 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,574 | 496 | 94.2% |
| Education | $592.66 | 10 | 5.8% |
| Travel and Lodging | $1.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $1,878 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $1,196 | 84 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,017 | 31 | $0 (2024) |
| ABBVIE INC. | $982.87 | 58 | $0 (2024) |
| Allergan, Inc. | $924.59 | 56 | $0 (2020) |
| Astellas Pharma US Inc | $915.80 | 33 | $0 (2024) |
| Insmed, Inc. | $745.47 | 28 | $0 (2024) |
| Gilead Sciences, Inc. | $666.34 | 43 | $0 (2024) |
| Melinta Therapeutics, LLC | $398.12 | 15 | $0 (2024) |
| Janssen Products, LP | $213.99 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,471 | 61 | ViiV Healthcare Company ($441.88) |
| 2023 | $1,343 | 68 | ViiV Healthcare Company ($386.69) |
| 2022 | $1,517 | 73 | Janssen Biotech, Inc. ($344.63) |
| 2021 | $956.90 | 52 | Astellas Pharma US Inc ($235.03) |
| 2020 | $983.52 | 43 | Allergan, Inc. ($288.36) |
| 2019 | $1,406 | 74 | Merck Sharp & Dohme Corporation ($438.90) |
| 2018 | $1,240 | 67 | Melinta Therapeutics, Inc. ($308.05) |
| 2017 | $1,250 | 69 | Janssen Biotech, Inc. ($284.48) |
All Payment Transactions
507 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: HIV | ||||||
| 12/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/02/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ANTIFUNGALS | ||||||
| 11/26/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: HIV | ||||||
| 11/25/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/21/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: HIV | ||||||
| 11/14/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 10/25/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: HIV | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: HIV | ||||||
| 10/01/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $115.82 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 09/13/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/12/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: HIV | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 09/10/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: ANTIFUNGALS | ||||||
| 08/23/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Infectious Diseases | ||||||
| 08/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 626 | 1,228 | $275,074 | $101,492 |
| 2022 | 7 | 717 | 1,438 | $311,522 | $117,813 |
| 2021 | 6 | 651 | 1,280 | $269,994 | $106,540 |
| 2020 | 7 | 616 | 1,394 | $232,565 | $124,854 |
Total Patients
2,610
Total Services
5,340
Medicare Billing
$450,700
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 238 | 548 | $93,725 | $37,503 | 40.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 257 | 297 | $84,495 | $33,546 | 39.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 203 | $45,675 | $10,555 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 98 | $26,694 | $10,005 | 37.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 53 | $13,620 | $5,500 | 40.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $10,866 | $4,383 | 40.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 270 | 665 | $102,908 | $41,318 | 40.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 269 | 295 | $87,649 | $34,615 | 39.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 148 | $32,783 | $13,237 | 40.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 17 | 180 | $40,500 | $10,296 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 94 | $25,925 | $9,621 | 37.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 39 | $16,840 | $6,758 | 40.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 16 | 17 | $4,918 | $1,970 | 40.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 259 | 607 | $86,073 | $38,115 | 44.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 227 | 243 | $72,019 | $29,063 | 40.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 13 | 207 | $46,575 | $12,839 | 27.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 92 | $25,725 | $10,115 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 55 | $23,384 | $9,532 | 40.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 76 | $16,219 | $6,876 | 42.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 167 | 493 | $49,300 | $31,639 | 64.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 111 | 294 | $39,690 | $27,219 | 68.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 133 | 137 | $41,100 | $24,625 | 59.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 116 | 122 | $33,550 | $15,170 | 45.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 14 | 203 | $45,675 | $12,467 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 133 | $19,950 | $11,983 | 60.1% |
About Dr. Jose Gaviria, M.D
Dr. Jose Gaviria, M.D is a Infectious Disease healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942207204.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Gaviria, M.D has received a total of $10,168 in payments from pharmaceutical and medical device companies, with $1,471 received in 2024. These payments were reported across 507 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($9,574).
As a Medicare-enrolled provider, Gaviria has provided services to 2,610 Medicare beneficiaries, totaling 5,340 services with total Medicare billing of $450,700. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Miami, FL
- Active Since 07/01/2005
- Last Updated 10/04/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1942207204
Products in Payments
- DOVATO (Drug) $1,135
- DALVANCE (Drug) $1,032
- AVYCAZ (Drug) $875.94
- Arikayce (Drug) $745.47
- PREZCOBIX (Drug) $659.15
- SYMTUZA (Drug) $641.11
- ZERBAXA (Drug) $536.74
- Cresemba (Drug) $350.74
- Baxdela (Drug) $308.05
- CABENUVA (Biological) $261.44
- VIBATIV (Drug) $211.46
- CRESEMBA (Drug) $187.87
- TRIUMEQ (Drug) $178.24
- XERAVA (Drug) $176.05
- PREVYMIS (Drug) $174.74
- APRETUDE (Biological) $167.73
- NUZYRA (Drug) $162.56
- Fetroja (Drug) $131.93
- Epclusa (Drug) $121.87
- VABOMERE (Drug) $109.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Miami
Douglas Brust, M.d, M.D
Infectious Disease — Payments: $450,213
Infectious Disease $450,213
Ricardo Fonseca Franco
Infectious Disease — Payments: $135,298
Infectious Disease $135,298
Hector Bolivar, Md, MD
Infectious Disease — Payments: $105,997
Infectious Disease $105,997
Jorge Murillo, Md, MD
Infectious Disease — Payments: $85,760
Infectious Disease $85,760
Dushyantha Jayaweera, Md, MD
Infectious Disease — Payments: $79,219
Infectious Disease $79,219
Dr. Lilian Abbo, Md, MD
Infectious Disease — Payments: $69,205
Infectious Disease $69,205